Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

Susan W. Broner, MD, the medical director of the Weill Cornell Medicine Headache Program, talked about the essentials of diagnosing and treating various headache disorders from a general neurology perspective.

Essentials for Treating Headache as a General Neurologist

Avidity Biosciences anticipates to provide new cohort data from the phase 1/2 EXPLORE44 trial assessing AOC 1044 in Duchenne muscular dystrophy mutations amenable to exon 44 skipping in the second half of 2024.

FDA Grants Rare Pediatric Disease Designation to Duchenne Agent AOC 1044 for Mutations Amenable to Exon 44 Skipping

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on Huntington disease.

NeurologyLive® Brain Games: May 19, 2024

Sean Pittock, MD, director for the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology detailed interim data from the open-label extension of the pivotal CHAMPION-NMOSD trial, the study that led to ravulizumab’s approval. 

Reviewing Ravulizumab’s Long-Term Profile as New NMOSD Treatment

Videos

The associate professor of neurology at Harvard Medical School talked about findings from a recent case series of patients with NMOSD initially on rituximab who then switched to inebilizumab. [WATCH TIME: 4 minutes]

Efficacy of Switching From to Inebilizumab in Rituximab in NMOSD: Michael Levy, MD, PhD

, has been with the team since October 2019. Follow him on Twitter 

Mayo's MOGAD Clinic represents a new type of novel, multidisciplinary care, incorporating multiple different backgrounds of neurology, neuroimmunology, neuro—ophthalmology, and urology, among others.

Building the Archetype for MOGAD Care: Introducing Mayo’s New Clinic

The Consortium of Multiple Sclerosis Centers' 38th Annual Meeting will be held Wednesday, May 29, through Saturday, June 1, 2024 at the Music City Center, in Nashville, Tennessee.

CMSC 2024: What to Expect From This Year's Annual Meeting

Cure SMA introduces tools aiding in SMA clinical trial navigation and participation empowerment.

Cure SMA Unveils Initiatives to Improve Clinical Trial Accessibility

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

YouTube

Spotlight

AAN 2024

MDA 2024

ACTRIMS 2024

Treating NMOSD: What's Next?

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Multiple Sclerosis Care in Diverse Patient Populations: Challenges and Solutions

Experts in neurology share considerations for the management of ethnically diverse and underrepresented populations including those of reproductive age.

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, discuss misconceptions surrounding pregnancy and multiple sclerosis and highlight how to approach conversations with this patient population.

Multiple Sclerosis and Pregnancy Misconceptions

Regina Berkovich, MD, PhD, provides insight into considerations regarding the management of pregnancy in patients with multiple sclerosis and highlights available resources and discussion points.

Considerations and Resources for Pregnant Patients With MS

Experts in neurology comment on factors relating to treatment selection in pregnancy for women with multiple sclerosis; highlighting efficacy and reversibility considerations of disease-modifying therapies.

Treatment Selection in MS and Pregnancy

Drs Jeffrey Dunn and Regina Berkovich provide insight into the biochemistry and reversibility of currently available S1P treatments for patients with multiple sclerosis.

S1P Receptor Modulator Therapy Reversibility Considerations

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, discuss rates of postpartum relapse in patients with multiple sclerosis and how they approach this topic with their patients.

Postpartum Relapse in Patients With MS

Experts in neurology explore the awareness of multiple sclerosis in ethnically diverse and underrepresented patient populations, commenting on the need for greater clinical trial inclusion. 

Clinical Trial Considerations for Ethnically Diverse, Underrepresented MS Patients

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, highlight the role of a multidisciplinary care team in engaging ethnically diverse and underrepresented patient populations with multiple sclerosis in clinical trials and practice.

Fostering Patient-Centered Care in Ethnically Diverse, Underrepresented MS Patients

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, share advice for building trust and individualizing treatment approaches in ethnically diverse and underrepresented patient populations with multiple sclerosis.

Building Trust in Ethnically Diverse and Underrepresented MS Patients

Regina Berkovich, MD, PhD, comments on the role of patient education in engaging ethnically diverse and underrepresented patient populations with multiple sclerosis in their treatment plans.

Patient Education in Ethnically Diverse and Underrepresented MS Patients

Experts in neurology discuss the considerations and practicalities of treating patients with multiple sclerosis who may undergo surgery and explore the role of treatment holidays.

Surgical Considerations for Patients With MS

Regina Berkovich, MD, PhD, provides insight on the considerations and patient awareness of the risk of infections with disease-modifying therapies in patients with multiple sclerosis. 

Considerations for Infection Risk in Patients With MS

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, provide an overview of the impact vaccinations and immunization may have on multiple sclerosis therapies, highlighting the ability of S1P treatments to remain effective. 

Immunogenicity and Disease-Modifying Therapies

Regina Berkovich, MD, PhD, shares her approach on the initiation and cessation of treatment for patients with multiple sclerosis who are considering family planning and vaccinations.

Family Planning and Vaccination Considerations for Patients With MS

Experts in neurology explore the benefits of a collaborative care approach for patients with multiple sclerosis.

The Benefits of Collaborative Care for Patients With MS

Drs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms. 

Tools and Resources for the Management of MS

Clinical

EMD-22-NRD0193 - /clinical/multiple-sclerosis

Considerations and Resources for Pregnant Patients With MS

EP: 1.Multiple Sclerosis and Pregnancy Misconceptions

EP: 2.Considerations and Resources for Pregnant Patients With MS

EP: 3.Treatment Selection in MS and Pregnancy

EP: 4.S1P Receptor Modulator Therapy Reversibility Considerations

EP: 5.Postpartum Relapse in Patients With MS

EP: 6.Clinical Trial Considerations for Ethnically Diverse, Underrepresented MS Patients

EP: 7.Fostering Patient-Centered Care in Ethnically Diverse, Underrepresented MS Patients

EP: 8.Building Trust in Ethnically Diverse and Underrepresented MS Patients

EP: 9.Patient Education in Ethnically Diverse and Underrepresented MS Patients

EP: 10.Surgical Considerations for Patients With MS

EP: 11.Considerations for Infection Risk in Patients With MS

EP: 12.Immunogenicity and Disease-Modifying Therapies

EP: 13.Family Planning and Vaccination Considerations for Patients With MS

EP: 14.The Benefits of Collaborative Care for Patients With MS

EP: 15.Tools and Resources for the Management of MS